1. Home
  2. FTRE vs DFP Comparison

FTRE vs DFP Comparison

Compare FTRE & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • DFP
  • Stock Information
  • Founded
  • FTRE 1996
  • DFP 2013
  • Country
  • FTRE United States
  • DFP United States
  • Employees
  • FTRE N/A
  • DFP N/A
  • Industry
  • FTRE Medical Specialities
  • DFP Investment Managers
  • Sector
  • FTRE Health Care
  • DFP Finance
  • Exchange
  • FTRE Nasdaq
  • DFP Nasdaq
  • Market Cap
  • FTRE 468.1M
  • DFP 417.1M
  • IPO Year
  • FTRE N/A
  • DFP N/A
  • Fundamental
  • Price
  • FTRE $6.80
  • DFP $20.53
  • Analyst Decision
  • FTRE Hold
  • DFP
  • Analyst Count
  • FTRE 11
  • DFP 0
  • Target Price
  • FTRE $16.00
  • DFP N/A
  • AVG Volume (30 Days)
  • FTRE 2.5M
  • DFP 56.2K
  • Earning Date
  • FTRE 08-06-2025
  • DFP 01-01-0001
  • Dividend Yield
  • FTRE N/A
  • DFP 6.73%
  • EPS Growth
  • FTRE N/A
  • DFP N/A
  • EPS
  • FTRE N/A
  • DFP N/A
  • Revenue
  • FTRE $2,685,600,000.00
  • DFP N/A
  • Revenue This Year
  • FTRE N/A
  • DFP N/A
  • Revenue Next Year
  • FTRE $0.93
  • DFP N/A
  • P/E Ratio
  • FTRE N/A
  • DFP N/A
  • Revenue Growth
  • FTRE N/A
  • DFP N/A
  • 52 Week Low
  • FTRE $3.97
  • DFP $15.45
  • 52 Week High
  • FTRE $27.99
  • DFP $19.31
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 69.65
  • DFP 48.29
  • Support Level
  • FTRE $4.46
  • DFP $20.39
  • Resistance Level
  • FTRE $6.85
  • DFP $21.00
  • Average True Range (ATR)
  • FTRE 0.47
  • DFP 0.19
  • MACD
  • FTRE 0.21
  • DFP -0.05
  • Stochastic Oscillator
  • FTRE 97.96
  • DFP 23.44

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.

Share on Social Networks: